Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 1:33 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 127 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Very Preterm Infant Clear all

Conditions: Infant, Premature, Diseases
Interventions: Medolac human milk based human milk fortifier (MHMHMF); Dietary Supplement
Lead sponsor: Northwest Health; Other
Eligibility: 23 Weeks to 32 Weeks
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Johnson, Arkansas

Conditions: Preterm Birth
Interventions: Deferred cord clamping; Procedure
Lead sponsor: University of Sydney; Other
Eligibility: Female only
Enrollment: 1,637 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2020
U.S. locations: 2
States / cities: Houston, Texas • Burlington, Vermont

Conditions: Retinopathy of Prematurity
Interventions: Omegaven, Standard lipids (primarily omega-6 fatty acids); Drug · Dietary Supplement
Lead sponsor: University of California, San Diego; Other
Eligibility: Up to 7 Days
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Prematurity, Very Preterm Maturity of Infant
Interventions: SNOO Smart Sleeper, Traditional bassinet; Device
Lead sponsor: Columbia University; Other
Eligibility: 1 Week to 12 Weeks
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Parenteral Nutrition-Associated Liver Disease
Interventions: Intravenous fat emulsion, Restriction of intravenous fat emulsion to 1 gm/kg/d; Other
Lead sponsor: Yale University; Other
Eligibility: 12 Hours to 48 Hours
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Very Low Birthweight
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: Up to 4 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Durham, North Carolina • Raleigh, North Carolina

Conditions: Very Preterm Maturity of Infant, Very Low Birth Weight Infant
Interventions: Standardized Fortification, Adjustable Fortification; Dietary Supplement
Lead sponsor: Children's National Research Institute; Other
Eligibility: Up to 4 Weeks
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2034
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Preterm Birth, Blood Transfusion Complication, Hypothermia
Interventions: Ranger blood warmer (3M Healthcare, Oakdale, Minnesota); Device
Lead sponsor: University of South Carolina; Other
Eligibility: 24 Weeks to 32 Weeks
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Prematurity
Interventions: Low dose PUFA, High dose PUFA, Placebo; Other
Lead sponsor: Mead Johnson Nutrition; Industry
Eligibility: Up to 3 Days
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Chicago, Illinois • Evanston, Illinois

Conditions: Premature Infant
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Up to 3 Years
Enrollment: 393 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Infant,Premature, Body Weight, Adiposity
Interventions: Assessment of infant body composition; Diagnostic Test
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 1 Day to 14 Days
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Bronchopulmonary Dysplasia
Interventions: Dexamethasone Early, Dexamethasone Late; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 13 Days to 15 Days
Enrollment: 371 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1992 – 1994
U.S. locations: 13
States / cities: Palo Alto, California • New Haven, Connecticut • Washington D.C., District of Columbia + 10 more

Conditions: Patent Ductus Arteriosus
Interventions: feeding, fasting; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 23 Weeks to 33 Weeks
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 14
States / cities: San Francisco, California • San Jose, California • Chicago, Illinois + 11 more

Conditions: Infantile Hemangioma, Very Low Birth Weight Infants
Interventions: topical 0.5% Timolol maleate, Control (placebo) group; Drug
Lead sponsor: Alice K. Gong; Other
Eligibility: Up to 6 Months
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature
Interventions: Standard Cord Clamping, Delayed Cord Clamping; Procedure
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 0 Minutes to 1 Minute
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000
U.S. locations: 4
States / cities: Birmingham, Alabama • Cincinnati, Ohio • Cleveland, Ohio + 1 more

Conditions: Prematurity, Light-For-Dates, Enteral Feeding Intolerance
Interventions: Early HMF, Delayed HMF; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 1 Day to 4 Days
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Ferritin Levels in Very Preterm Infants
Interventions: maternal breast milk, Donor breast milk; Other
Lead sponsor: AdventHealth; Other
Eligibility: 2 Weeks to 4 Weeks
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Prematurity, Respiratory Distress Syndrome, Patent Ductus Arteriosus
Interventions: Survanta (beractant), Curosurf (poractant); Drug
Lead sponsor: Alan Fujii; Other
Eligibility: Up to 8 Hours
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Hypotension, Blood Pressure
Interventions: Dopamine, Hydrocortisone, Infusion Placebo, Syringe Placebo; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 24 Hours
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 17
States / cities: Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 13 more

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Bronchopulmonary Dysplasia (BPD)
Interventions: Not listed
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 36 Weeks to 37 Weeks
Enrollment: 410 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 21
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 17 more

Conditions: Infant, Very Low Birth Weight, Infant, Premature, Ductus Arteriosus, Patent
Interventions: Indomethacin, Placebo; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 2 Hours to 6 Hours
Enrollment: 1,202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2001
U.S. locations: 9
States / cities: Birmingham, Alabama • Palo Alto, California • Miami, Florida + 6 more

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Sepsis, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections
Interventions: Not listed
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 72 Hours
Enrollment: 615 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 19
States / cities: Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 15 more

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Retinopathy of Prematurity, Bronchopulmonary Dysplasia (BPD)
Interventions: Inositol lower volume, Inositol mid-level volume, Inositol high volume, Placebo low volume; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 12 Hours to 72 Hours
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 17
States / cities: Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 13 more

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Electroencephalography
Interventions: Not listed
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 72 Hours
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 8
States / cities: Palo Alto, California • Atlanta, Georgia • Detroit, Michigan + 4 more

Search by objective public record fields.

Novel Human Milk Based Human Milk Fortifier

The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?

Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity

Sleep in SNOO Smart Sleeper Bassinet in Preterm Infants

Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates

Mother Sibling Interactions Following Very Low Birth Weight (VLBW) Infant Homecoming

Individualized Nutrition to Optimize Preterm Infant Growth and Neurodevelopment

Blood Warming in Preterm Infants to Decrease Hypothermia

Early DHA Supplementation in Very Low Birth Weight Infants

Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)

Serial Assessment of Body Fat Accrual in Very Preterm Infants

Dexamethasone Therapy in VLBW Infants at Risk of CLD

Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants

Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)

Delayed Cord Clamping in VLBW Infants

Early Human Milk Fortification After Early, Exclusive, Enteral Nutrition in Very Preterm Infants

Donor Breast Milk and Serum Ferritin Levels in Very Preterm Infants

Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants

Early Blood Pressure Management in Extremely Premature Infants

Physiologic Definition of Bronchopulmonary Dysplasia

Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)

Early-Onset Sepsis Surveillance Study

Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)

Cerebral Function Monitoring in Premature Infants